BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4140560)

  • 21. Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.
    Swanborg RH
    J Immunol; 1973 Oct; 111(4):1067-70. PubMed ID: 4728676
    [No Abstract]   [Full Text] [Related]  

  • 22. Humoral immune response in guinea pigs at different stages of experimental allergic encephalomyelitis.
    Lassmann H; Karcher D; Kitz K; Lowenthal A; Noppe M; Verslegers W
    Prog Clin Biol Res; 1984; 146():171-8. PubMed ID: 6201887
    [No Abstract]   [Full Text] [Related]  

  • 23. [The demyelinating effect of immune lymphocytes in nerve tissue cultures].
    Gervazieva VB
    Biull Eksp Biol Med; 1973 Feb; 74(2):55-8. PubMed ID: 4374973
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvanticity of synthetic polynucleotides for induction of experimental allergic encephalomyelitis in guinea pigs.
    Paterson PY; Drobish DG
    J Immunol; 1974 Dec; 113(6):1942-6. PubMed ID: 4139200
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of adjuvanticity in rats for the hyperacute form of allergic encephalomyelitis and for reaginic antibody production in mice of a phenotypic variant of Bordetella pertussis.
    Wardlaw AC; Parton R; Bergman RK; Munoz JJ
    Immunology; 1979 Jul; 37(3):539-45. PubMed ID: 500113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
    J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-inflammatory expression of fibronectin (Fn) and Ia in acute experimental allergic encephalomyelitis (EAE): modulation of endothelial cells (EC) in the immune response detected by quantitative immunoperoxidase studies using monoclonal antibodies (MAb).
    Sobel RA; Blanchette BW; Colvin RB
    Prog Clin Biol Res; 1984; 146():81-6. PubMed ID: 6201925
    [No Abstract]   [Full Text] [Related]  

  • 31. Oligoclonal IgG in Lewis rats with experimental allergic encephalomyelitis.
    Whittaker KM; Whitacre CC
    Prog Clin Biol Res; 1984; 146():335-40. PubMed ID: 6201905
    [No Abstract]   [Full Text] [Related]  

  • 32. The antibody response to myelin basic protein (BP) in Lewis rats: the effect of time, dosage of BP, and dosage of Mycobacterium butyricum.
    Day ED; Pitts OM
    J Immunol; 1974 Dec; 113(6):1958-67. PubMed ID: 4139202
    [No Abstract]   [Full Text] [Related]  

  • 33. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 34. Anaphylactic release of histamine from guinea pig skin in vitro.
    Yeoh TS; Tay CH; Greaves MW
    Int Arch Allergy Appl Immunol; 1972; 42(3):485-90. PubMed ID: 4111965
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination with a synthetic T-cell receptor V-region peptide: immunomodulation or vaccination.
    Kaneko H; Iizuka K; Kokai Y; Fujimoto JI; Hirasawa A; Tsujimoto G; Koike H; Torres-Nagel N; Hunig T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1539-42. PubMed ID: 7536968
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous vascular permeability factors (histamine, 5-hydroxytryptamine, bradykinin) and passive cutaneous anaphylaxis in sheep.
    Eyre P
    J Pharm Pharmacol; 1970 Feb; 22(2):104-9. PubMed ID: 4392243
    [No Abstract]   [Full Text] [Related]  

  • 37. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.
    Hughes RA
    Immunology; 1974 Apr; 26(4):703-11. PubMed ID: 4212280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 39. An immunobiological approach to the pathogenesis of experimental allergic encephalomyelitis in chickens.
    Yamaguchi Y; Niedieck B; Palacios O
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:334-44. PubMed ID: 5373032
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneity of guinea-pig homocytotropic antibodies.
    Perini A; Mota I
    Immunology; 1972 May; 22(5):915-23. PubMed ID: 4401794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.